sarcosine has been researched along with cholylsarcosine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (47.62) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofmann, AF; Lillienau, J; Schteingart, CD | 1 |
| Danzinger, RG; Esch, O; Hofmann, AF; Kim, YS; Lillienau, J; Longmire-Cook, SJ; Schteingart, CD | 1 |
| Heuman, DM; Hofmann, AF; Hylemon, PB; Kim, YS; Lillienau, J; Pandak, WM; Vlahcevic, ZR | 1 |
| Angellotti, MA; Hofmann, AF; Marcus, SN; Rossi, SS; Schmassmann, A; Schteingart, CD; Ton-Nu, HT | 1 |
| Fehr, HF; Hofmann, AF; Lillienau, J; Locher, J; Rossi, SS; Schmassmann, A; Schteingart, CD | 1 |
| Hagey, LR; Hofmann, AF; Jorgensen, RA; Lindor, KD; Ricci, P; Rolland Dickson, E | 1 |
| Fordtran, JS; Gruy-Kapral, C; Hagey, LR; Hofmann, AF; Little, KH; Meziere, TL | 1 |
| Stein, J; Weinand, I | 1 |
| Heydorn, S; Jeppesen, PB; Mortensen, PB | 1 |
| Jojić, N; Necić, D; Popović, OS | 1 |
| Dillmann, R; Drewe, J; Fahr, A; Fricker, G; Michael, S; Thöle, M | 1 |
| Emmett, M; Fordtran, JS; Guirl, MJ; Hofmann, AF; Neimark, S; Porter, JL; Santa Ana, CA | 1 |
| Alvarez, MA; Ausina, V; Bartolí, R; Gassull, MA; Hagey, LR; Hernández, JM; Hofmann, AF; Lorenzo-Zúñiga, V; Mañé, J; Planas, R; Viñado, B | 1 |
| Hofmann, AF; Kapral, C; Lenz, K; Praxmarer, V; Wewalka, F | 1 |
| Bott, C; Dressman, JB; Fürst, T; Stein, J | 1 |
| Chen, F; Chen, X; Dawson, PA; Glaeser, H; Hofmann, AF; Kim, RB; Liu, S; Pang, KS; Shneider, BL | 1 |
| Fricker, G; Hartmann, FJ; Parmentier, J | 1 |
| Alstrup, AK; Frisch, K; Hofmann, AF; Jakobsen, S; Keiding, S; Munk, OL; Ott, P; Sørensen, M | 1 |
| Alstrup, AK; Andersen, KJ; Frisch, K; Hofmann, AF; Keiding, S; Mortensen, FV; Munk, OL; Ott, P; Sørensen, M; Ørntoft, NW | 1 |
| Frisch, K; Keiding, S; Munk, OL; Ott, P; Sørensen, M; Ørntoft, NW | 1 |
| Frisch, K; Keiding, S; Ott, P; Sørensen, M; Ørntoft, N | 1 |
1 review(s) available for sarcosine and cholylsarcosine
| Article | Year |
|---|---|
Functional assessment of hepatobiliary secretion by
Topics: Anti-Bacterial Agents; Bile Acids and Salts; Bile Ducts; Carbon Radioisotopes; Chemical and Drug Induced Liver Injury; Cholestasis; Cholic Acids; Feasibility Studies; Female; Humans; Liver; Middle Aged; Molecular Imaging; Pneumonia; Positron-Emission Tomography; Radioactive Tracers; Sarcosine | 2018 |
3 trial(s) available for sarcosine and cholylsarcosine
| Article | Year |
|---|---|
Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome.
Topics: Aged; Analysis of Variance; Calorimetry; Cholic Acids; Cross-Over Studies; Dietary Fats; Energy Intake; Energy Metabolism; Fats; Feces; Female; Food, Formulated; Humans; Intestinal Absorption; Male; Middle Aged; Sarcosine; Short Bowel Syndrome | 1999 |
Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome.
Topics: Adult; beta Carotene; Chemistry, Pharmaceutical; Cholic Acids; Excipients; Feces; Female; Humans; Hydrogen-Ion Concentration; Lipids; Microscopy, Electron, Scanning; Middle Aged; Particle Size; Pilot Projects; Polymethacrylic Acids; Powders; Sarcosine; Short Bowel Syndrome; Solubility; Tablets, Enteric-Coated | 2005 |
Hepatobiliary transport kinetics of the conjugated bile acid tracer
Topics: Aged; Bile; Bile Acids and Salts; Biological Transport, Active; Carbon Radioisotopes; Case-Control Studies; Cholestasis; Cholic Acids; Female; Humans; Kinetics; Liver; Liver Circulation; Male; Middle Aged; Positron-Emission Tomography; Sarcosine; Young Adult | 2017 |
17 other study(ies) available for sarcosine and cholylsarcosine
| Article | Year |
|---|---|
Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.
Topics: Animals; Bile Acids and Salts; Calcium; Cholic Acids; Colon; Humans; Intestine, Small; Lipolysis; Magnetic Resonance Spectroscopy; Malabsorption Syndromes; Micelles; Rabbits; Sarcosine; Solubility | 1992 |
Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.
Topics: Absorption; Animals; Bile Acids and Salts; Body Weight; Cholic Acids; Diarrhea; Dietary Fats; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastrointestinal Contents; Ileum; Malabsorption Syndromes; Male; Sarcosine; Time Factors | 1992 |
Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile secretion in rats.
Topics: Animals; Bile Acids and Salts; Biliary Fistula; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholic Acids; Glycocholic Acid; Liver; Male; Phospholipids; Rats; Rats, Sprague-Dawley; Sarcosine; Taurocholic Acid | 1992 |
Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation.
Topics: Animals; Bile; Biological Transport; Biotransformation; Cholic Acids; Cricetinae; Enterohepatic Circulation; Ileum; Intestinal Absorption; Male; Rabbits; Rats; Sarcosine; Taurocholic Acid | 1990 |
Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Biotransformation; Cholecystectomy; Cholelithiasis; Cholic Acids; Duodenum; Female; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged; Reference Values; Sarcosine; Time Factors | 1993 |
Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
Topics: Adult; Cholagogues and Choleretics; Cholesterol; Cholic Acids; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Sarcosine; Ursodeoxycholic Acid | 1998 |
Conjugated bile acid replacement therapy for short-bowel syndrome.
Topics: Animals; Aspartate Aminotransferases; Bile Acids and Salts; Body Weight; Cattle; Cholic Acids; Diarrhea; Dietary Fats; Energy Intake; Feces; Female; Follow-Up Studies; Humans; Ileostomy; Intestinal Absorption; Middle Aged; Sarcosine; Short Bowel Syndrome | 1999 |
[Cholysarkosin in treatment of bile acid deficiency syndrome].
Topics: Administration, Oral; Bile Acids and Salts; Celiac Disease; Cholic Acids; Diarrhea; Humans; Ileum; Intestinal Absorption; Malabsorption Syndromes; Sarcosine; Short Bowel Syndrome; Treatment Outcome | 1999 |
Cholylsarcosine for bile acid deficiency caused by ileal resection.
Topics: Adult; Animals; Bile Acids and Salts; Cholic Acids; Dogs; Female; Humans; Ileum; Male; Postoperative Complications; Sarcosine | 1999 |
Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine.
Topics: Animals; Area Under Curve; Bile Acids and Salts; Caco-2 Cells; Cell Membrane Permeability; Cell Survival; Cholic Acids; Dextrans; Electric Impedance; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Intestinal Absorption; Male; Membranes, Artificial; Peptides; Rats; Rats, Wistar; Sarcosine; Stimulation, Chemical | 2000 |
Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
Topics: Administration, Oral; Aged; Animals; Calcium Oxalate; Cattle; Celiac Disease; Cholic Acids; Feces; Humans; Hyperoxaluria; Male; Outpatients; Sarcosine; Short Bowel Syndrome; Urine | 2003 |
Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
Topics: Animals; Bacteria; Bacterial Translocation; Bile; Bile Acids and Salts; Cholic Acids; Endotoxemia; Glycocholic Acid; Ileum; Intestines; Liver Cirrhosis, Experimental; Male; Placebos; Rats; Rats, Sprague-Dawley; Sarcosine | 2003 |
Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.
Topics: Aged; Animals; Bile Acids and Salts; Body Mass Index; Body Weight; Cattle; Cholic Acids; Diarrhea; Dietary Fats; Female; Humans; Intestinal Absorption; Intestine, Small; Male; Middle Aged; Postoperative Complications; Sarcosine; Short Bowel Syndrome; Steatorrhea; Treatment Outcome | 2004 |
Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor.
Topics: Animals; Bile Acids and Salts; Biological Transport; Caco-2 Cells; Calcitriol; Cholic Acids; Erythrocytes; Gene Expression; Humans; Intestine, Small; Mutation; Organic Anion Transporters, Sodium-Dependent; Perfusion; Promoter Regions, Genetic; Rats; Receptors, Calcitriol; Retinoid X Receptors; RNA, Messenger; Sarcosine; Sequence Deletion; Symporters; Transcriptional Activation; Vitamin D Response Element | 2006 |
In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.
Topics: Administration, Oral; Amines; Caco-2 Cells; Cholesterol; Cholic Acids; Dextrans; Drug Carriers; Drug Delivery Systems; Fluorescein-5-isothiocyanate; Humans; Liposomes; Macromolecular Substances; Phosphatidylcholines; Polyethylene Glycols; Sarcosine; Vitamin E | 2010 |
[N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs.
Topics: Animals; Bile Acids and Salts; Carbon Radioisotopes; Cholic Acids; Female; Liver; Liver Function Tests; Multimodal Imaging; Positron-Emission Tomography; Radioactive Tracers; Radiochemistry; Sarcosine; Swine; Tomography, X-Ray Computed | 2012 |
Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11C-Cholylsarcosine PET.
Topics: Animals; Biliary Tract; Carbon Radioisotopes; Cholic Acids; Female; Kinetics; Liver; Positron-Emission Tomography; Sarcosine; Swine | 2016 |